As of 2025-07-08, the EV/EBITDA ratio of Dicerna Pharmaceuticals Inc (DRNA) is -22.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRNA's latest enterprise value is 2,729.79 mil USD. DRNA's TTM EBITDA according to its financial statements is -119.65 mil USD. Dividing these 2 quantities gives us the above DRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 14.0x | 13.5x |
| Forward P/E multiples | 22.9x - 28.4x | 26.7x |
| Fair Price | (34.01) - (19.89) | (29.56) |
| Upside | -189.0% - -152.0% | -177.3% |
| Date | EV/EBITDA |